tiprankstipranks
Trending News
More News >
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
US Market

Chemomab Therapeutics (CMMB) Income Statement

Compare
257 Followers

Chemomab Therapeutics Income Statement

Last quarter (Q4 2024), Chemomab Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Chemomab Therapeutics's net income was $-2.96M. See Chemomab Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -66.83K$ -57.77K$ -34.02K$ -80.00K
Operating Expenses
$ 14.74K$ 25.46M$ 28.53M$ 12.37M$ 5.97M
Depreciation and Amortization
$ 53.25K$ 67.00K$ 57.77K$ 34.02K$ 80.00K
EBITDA
$ -14.67K$ -25.39M$ -28.48M$ -12.33M$ -5.95M
Operating Income
$ -14.74K$ -25.46M$ -28.53M$ -12.37M$ -5.97M
Other Income/Expenses
$ 794.00K$ 1.24M$ 353.00K$ -111.00K$ 21.00K
Pretax Income
$ -13.95K$ -24.22M$ -28.18M$ -12.48M$ -5.95M
Net Income
$ -13.95K$ -24.22M$ -27.65M$ -12.48M$ -5.95M
Per Share Metrics
Basic EPS
$ -0.36$ -2.06$ -2.42$ -1.20$ -6.30
Diluted EPS
$ -0.36$ -2.06$ -2.42$ -1.20$ -6.30
Weighted Average Shares Outstanding
17.95M 11.75M 11.38M 10.37M 1.85M
Weighted Average Shares Outstanding (Diluted)
17.95M 11.75M 11.38M 10.37M 1.85M
Currency in USD

Chemomab Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis